5 recruiting, 4 completed, 4 unknown, 2 not yet recruiting. 4 Phase 4, 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Pneumocystis Pneumonia: new trials by email Literature Review of Pneumocystis Pneumonia trials Research Report on Pneumocystis Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| How Long Should we Give Steroids for Patients With Severe PCP Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 416 | 2026-01-30 | 2026-01-09 |
| CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection | Phase 1 / Phase 2 | Recruiting | University Hospital, Tours | 100 | 2025-12-02 | 2026-10-09 |
| Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia | Phase 3 | Recruiting | Todd C. Lee MD MPH FIDSA | 416 | 2025-11-28 | 2026-02-20 |
| Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia | Recruiting | Azienda Ospedaliero-Universitaria Careggi | 400 | 2025-11-13 | 2026-07-02 | |
| Pneumocystis Jirovecii Genotyping Pneumocystis Pneumonia | Not yet recruiting | Nottingham University Hospitals NHS Trust | 70 | 2025-09-01 | 2025-06-27 | |
| Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii Pneumocystis Pneumonia | Active not recruiting | University Hospital, Brest | 300 | 2024-06-01 | 2024-08-09 | |
| Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults Co-Trimoxazole, Rezafungin Acetate / Co Trimoxazole - Pneumocystis Pneumonia | Phase 2 | Recruiting | Mundipharma Research Limited | 50 | 2023-11-14 | 2025-04-03 |
| Caspofungin for Pneumocystis Pneumonia in PLWHIV. HIV-1-infection, Pneumocystis Pneumonia | Recruiting | Instituto Nacional de Enfermedades Respiratorias | 60 | 2023-08-01 | 2024-11-19 | |
| PCP in Immunocompromised Population in Southern China PCR was used to detect pneumocystis in respiratory specimens - Immunocompromised Patients, Pneumocystis Pneumonia | Unknown | First Affiliated Hospital of Guangxi Medical University | 300 | 2021-05-12 | 2022-11-04 | |
| Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate Aspergillus specific proteins in exhaled breath condensate (EBC), Pneumocystis jirovecii DNA in exhaled breath condensate (EBC) - Aspergillosis Pneumonia, Pneumocystis Pneumonia | Completed | Inger Lise Gade | 101 | 2020-04-17 | 2024-02-13 | |
| Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP caspofungin, TMP/SMZ(trimethoprim/sulfisoxazole), Methylprednisolone - Pneumocystis Pneumonia | Phase 4 | Unknown | Bin Du | 122 | 2019-08-14 | 2019-09-12 |
| Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Cotrimoxazole, Placebo - HIV-1-infection, Pneumocystis Pneumonia | Phase 4 | Completed | University of Bergen | 537 | 2017-03-30 | 2019-10-02 |
| A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT Pneumocystis Pneumonia | Completed | European Society for Blood and Marrow Transplantation | 168 | 2016-03-01 | 2023-05-15 | |
| Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients caspofungin, corticosteroids, Sulfanilamides - Pneumocystis Pneumonia | Not applicable | Unknown | Beijing Chao Yang Hospital | 60 | 2015-11-01 | 2020-03-13 |
| Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Dapsone, HLA-B*1301 - Allergic Cutaneous Vasculitis, Urticaria | Phase 4 | Unknown | Shandong Provincial Institute of Dermatology and Venereology | 3130 | 2015-07-01 | 2017-03-03 |
| Pneumocystis in Pathogenesis of HIV-associated Emphysema HIV Infections, Pneumocystis Pneumonia | Completed | University of Pittsburgh | 250 | 2007-08-01 | 2020-10-08 |
Pneumonia, Pneumocystis (16) · Pneumocystis Infections (3) · Pneumonia (3) · Infections (2) · Acne Vulgaris (1) · Asthma (1) · Coinfection (1) · Communicable Diseases (1) · Community-Acquired Pneumonia (1) · Disease (1) · Emergencies (1) · Emphysema (1) · HIV Infections (1) · Invasive Pulmonary Aspergillosis (1) · Leprosy (1)
Bacterial Infections and Mycoses (16) · Lung Diseases (16) · Lung Diseases, Fungal (16) · Respiratory Tract Diseases (16) · Mycoses (15) · Respiratory Tract Infections (15) · Infections (14) · Pneumocystis Infections (13) · Pneumonia (13) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Disease Attributes (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2)
Caspofungin (3) · Trimethoprim, Sulfamethoxazole Drug Combination (3) · Methylprednisolone (2) · Adrenal Cortex Hormones (1) · Dapsone (1) · Off-Label Use (1) · Rezafungin (1) · Sulfanilamides (1) · Sulfisoxazole (1)
Azienda Ospedaliero-Universitaria Careggi (1) · Beijing Chao Yang Hospital (1) · Bin Du (1) · European Society for Blood and Marrow Transplantation (1) · First Affiliated Hospital of Guangxi Medical University (1) · Inger Lise Gade (1) · Instituto Nacional de Enfermedades Respiratorias (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Mundipharma Research Limited (1) · Nottingham University Hospitals NHS Trust (1) · Shandong Provincial Institute of Dermatology and Venereology (1) · Todd C. Lee MD MPH FIDSA (1) · University Hospital, Brest (1) · University Hospital, Tours (1) · University of Bergen (1)
China (4) · France (3) · Canada (2) · Belgium (1) · Denmark (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Mexico (1) · Norway (1) · South Africa (1) · Tanzania (1) · United States (1)
Alison Morris-Gimbel, MD (1) · Christine Robin, MD (1) · Cunwei Cao, MD (1) · Emily G McDonald, MD MSc (1) · Furen Zhang (1) · Inger L Gade, MD PhD (1) · Joel Manyahi, MD (1) · Lorenzo Pelagatti, MD, PhD (1) · Mohit Joshi, MD (1) · Santiago Avila, PhD (1) · Simone Cesaro, MD (1) · Todd C Lee, MD MPH FIDSA (1)
PMID 41151592, PMID 15504856, PMID 16304338, PMID 18046534, PMID 20946413, PMID 22548840, PMID 23940606, PMID 26935726, PMID 29313714, PMID 29514207, PMID 30776290, PMID 31548210, PMID 31633150, PMID 32194238, PMID 32653726, PMID 33213011, PMID 33538349, PMID 33586013, PMID 34682270, PMID 34682277, PMID 35863836, PMID 36803640, PMID 37656874, PMID 9872631
2023 (1), R01HL083461 (1)